GILEAD SCIENCES, INC. — Director's Dealing 2017

Sep 1, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2017-08-30

Reporting Person: Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-30	Common Stock	M	22124	$24.905	Acquired	113237	Direct
2017-08-30	Common Stock	M	21001	$26.99	Acquired	134238	Direct
2017-08-30	Common Stock	S	50000	$79.00	Disposed	84238	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-08-30	Non-qualified Stock Option (Right to Buy)	$24.905	M	22124	Disposed	2019-07-29	Common Stock (22124)	Direct
2017-08-30	Non-qualified Stock Option (Right to Buy)	$26.99	M	21001	Disposed	2018-07-30	Common Stock (21001)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.